EVP Michael David sold 2,838 shares of BDX at $223.33; holdings drop 31.6% to 6,141 shares
Michael David, EVP & President Medical at Becton Dickinson, sold 2,838 shares on 2024-12-19 at $223.33, reducing his post-transaction holdings from 8,979 to 6,141 shares—a reduction of 31.6% of his prior holdings. The sale occurred at a price $4.35 below the current market price of $227.68, placing the transaction within recent trading activity but below the 52-week high of $247.73. With the company reporting 4.2% annual revenue growth and a P/E of 40.30, this is a material reduction in an executive's direct stake rather than a routine small-scale rebalancing. The magnitude of the holding reduction—nearly one-third—warrants investor attention to understand the business context and whether this reflects broader patterns among company leadership.